Acutaas Chemicals (ACUTAAS) Fundamentals 2026 — P/E 277.0x, Revenue Analysis | SniperIQ
Acutaas Chemicals (ACUTAAS) is a India-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ₹30,026 Crore, trading at ₹3667.50 on the BSE. This SniperIQ fundamentals page covers Acutaas Chemicals's valuation (P/E 277.0x, P/B 22.7x), profitability (net margin 20.7%), revenue (₹1,007 Crore in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Acutaas Chemicals's market cap?
Acutaas Chemicals (ACUTAAS) has a market capitalization of approximately ₹30,026 Crore, trading at ₹3667.50 on the BSE. Market cap moves with the live share price.
What is Acutaas Chemicals's P/E ratio?
Acutaas Chemicals's trailing twelve-month P/E ratio is 277.0x, with a price-to-book (P/B) of 22.7x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Acutaas Chemicals?
Acutaas Chemicals runs a net profit margin of 20.7%, a gross margin of 49.7%, and an operating margin of 40.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Acutaas Chemicals generate?
Acutaas Chemicals reported revenue of ₹1,007 Crore for fiscal year 2025, with net income of ₹159 Crore and earnings per share (EPS) of 19.81. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Acutaas Chemicals pay a dividend?
Acutaas Chemicals offers a trailing dividend yield of about 0.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Acutaas Chemicals financially healthy?
Acutaas Chemicals carries a debt-to-equity ratio of 0.00x and a current ratio of 0.00x, with a market beta of -0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Acutaas Chemicals a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Acutaas Chemicals (ACUTAAS) the key facts are: market cap ₹30,026 Crore, P/E 277.0x, revenue ₹1,007 Crore, 52-week range 1126-3735. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Acutaas Chemicals's full fundamentals live
Get Acutaas Chemicals's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.